Page last updated: 2024-11-05

triazolam and Disease Models, Animal

triazolam has been researched along with Disease Models, Animal in 7 studies

Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.

Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's3 (42.86)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kusunoki, Y1
Ikarashi, N2
Hayakawa, Y1
Ishii, M1
Kon, R1
Ochiai, W2
Machida, Y1
Sugiyama, K2
Hirase, M1
Ishida, T2
Kamei, C2
Wisor, JP1
Jiang, P1
Striz, M1
O'Hara, BF1
Kudo, T1
Shimada, T1
Toda, T1
Igeta, S1
Suzuki, W1
Ito, K1
Aburada, M1
Obara, Y1
Tsutsui, R1
Torr, SR1
Haskel, EJ1
VonVoigtlander, PF1
Bergmann, SR1
Abendschein, DR1
Piot, O1
Betschart, J1
Stutzmann, JM1
Blanchard, JC1

Other Studies

7 other studies available for triazolam and Disease Models, Animal

ArticleYear
Hepatic early inflammation induces downregulation of hepatic cytochrome P450 expression and metabolic activity in the dextran sulfate sodium-induced murine colitis.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2014, Apr-11, Volume: 54

    Topics: Animals; Cell Nucleus; Colitis, Ulcerative; Constitutive Androstane Receptor; Cytochrome P-450 Enzym

2014
Rebound insomnia induced by abrupt withdrawal of hypnotics in sleep-disturbed rats.
    European journal of pharmacology, 2008, Nov-12, Volume: 597, Issue:1-3

    Topics: Animals; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Sch

2008
Effects of ramelteon and triazolam in a mouse genetic model of early morning awakenings.
    Brain research, 2009, Nov-03, Volume: 1296

    Topics: Animals; Circadian Rhythm; Darkness; Disease Models, Animal; Indenes; Locomotion; Male; Mice; Mice,

2009
Altered expression of CYP in TSOD mice: a model of type 2 diabetes and obesity.
    Xenobiotica; the fate of foreign compounds in biological systems, 2009, Volume: 39, Issue:12

    Topics: Animals; Cytochrome P-450 Enzyme System; Dexamethasone; Diabetes Mellitus, Type 2; Disease Models, A

2009
Effect of ethanol on sleep-awake state in sleep-disturbed rats.
    Biological & pharmaceutical bulletin, 2010, Volume: 33, Issue:5

    Topics: Animals; Disease Models, Animal; Ethanol; Hypnotics and Sedatives; Male; Rats; Rats, Wistar; Referen

2010
Inhibition of cyclic flow variations and reocclusion after thrombolysis in dogs by a novel antagonist of platelet-activating factor.
    Journal of the American College of Cardiology, 1991, Volume: 18, Issue:7

    Topics: Administration, Oral; Animals; Benzodiazepines; Bleeding Time; Blood Coagulation; Blood Flow Velocit

1991
Cyclopyrrolones, unlike some benzodiazepines, do not induce physical dependence in mice.
    Neuroscience letters, 1990, Sep-04, Volume: 117, Issue:1-2

    Topics: Animals; Azabicyclo Compounds; Carbolines; Convulsants; Diazepam; Disease Models, Animal; Flunitraze

1990